✦ LIBER ✦

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis

✍ Scribed by Vosslamber, S; van der Voort, L F; van den Elskamp, I J; Heijmans, R; Aubin, C; Uitdehaag, B M J; Crusius, J B A; van der PouwKraan, T C T M; Comabella, M; Montalban, X

Book ID: 109855013
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 368 KB
Volume: 12
Category: Article
ISSN: 1466-4879
DOI: 10.1038/gene.2011.18

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Real-life impact of early interferonβ th

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

✍ M. Trojano; F. Pellegrini; D. Paolicelli; A. Fuiani; G.B. Zimatore; C. Tortorell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

## Abstract ## Objective Recent findings support greater efficacy of early vs. delayed interferon beta (IFNβ) treatment in patients with a first clinical event suggestive of multiple sclerosis (MS). We aimed to evaluate the effectiveness of early IFNβ treatment in definite relapsing‐remitting MS (

Are magnetic resonance findings predicti

Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-β

✍ Prof. W. I. McDonald; D. H. Miller; A. J. Thompson 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

Frequency and severity of headache is wo

Frequency and severity of headache is worsened by Interferon-β therapy in patients with multiple sclerosis

✍ F. Patti; A. Nicoletti; A. Pappalardo; A. Castiglione; S. Lo Fermo; S. Messina; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Mechanism for transcriptional synergy be

Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-β gene promoter

✍ Hongmei Yang; Gang Ma; Charles H. Lin; Melissa Orr; Marc G. Wathelet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Validation of IRF5 as multiple sclerosis

Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection

✍ Vandenbroeck, K; Alloza, I; Swaminathan, B; Antigüedad, A; Otaegui, D; Olascoaga 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 244 KB

Interleukin-1β represses MRP2 gene expre

Interleukin-1β represses MRP2 gene expression through inactivation of interferon regulatory factor 3 in HepG2 cells

✍ Keiji Hisaeda; Akihiko Inokuchi; Takanori Nakamura; Yukihide Iwamoto; Kimitoshi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB